EBSCO Logo
Connecting you to content on EBSCOhost
Results
Title

Lipid goal attainment in diabetes mellitus patients after acute coronary syndrome: a subanalysis of Dyslipidemia International Study II-China.

Authors

Guo, Tongshuai; Chu, Chao; Wang, Yang; He, Mingjun; Jia, Hao; Sun, Yue; Wang, Dan; Liu, Yan; Huo, Yong; Mu, Jianjun

Abstract

Background: Lipid management with a low-density lipoprotein cholesterol (LDL-C) goal of < 1.4 mmol/L is recommended for patients with acute coronary syndrome (ACS) and diabetes mellitus (DM) due to a high risk for adverse cardiovascular events. This study evaluated the lipid-lowering treatment (LLT) pattern and the LDL-C goal attainment rate in this special population. Methods: DM patients were screened from the observational Dyslipidemia International Study II-China study which assessed LDL-C goal attainment in Chinese ACS patients. The baseline characteristics between the LLT and no pre-LLT groups were compared. The proportions of patients obtaining LDL-C goal at admission and at 6-months, the difference from the goal, and the pattern of the LLT regimen were analyzed. Results: Totally 252 eligible patients were included, with 28.6% taking LLT at admission. Patients in the LLT group were older, had a lower percentage of myocardial infarction, and had decreased levels of LDL-C and total cholesterol compared to those in the no pre-LLT group at baseline. The overall LDL-C goal attainment rate was 7.5% at admission and increased to 30.2% at 6 months. The mean difference between the actual LDL-C value and LDL-C goal value dropped from 1.27 mmol/L at baseline to 0.80 mmol/L at 6 months. At 6 months, 91.4% of the patients received statin monotherapy, and only 6.9% received a combination of statin and ezetimibe. The atorvastatin-equivalent daily statin dosage was moderate during the study period. Conclusion: The low rate of lipid goal attainment observed was in line with the outcomes of other DYSIS-China studies.

Subjects

CHINA; ACUTE coronary syndrome; PEOPLE with diabetes; LDL cholesterol; DIABETES; DYSLIPIDEMIA

Publication

BMC Cardiovascular Disorders, 2023, Vol 23, Issue 1, p1

ISSN

1471-2261

Publication type

Academic Journal

DOI

10.1186/s12872-023-03312-w

EBSCO Connect | Privacy policy | Terms of use | Copyright | Manage my cookies
Journals | Subjects | Sitemap
© 2025 EBSCO Industries, Inc. All rights reserved